Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Number of holders
-
518
-
Total 13F shares, excl. options
-
538,274,425
-
Shares change
-
-49,924,069
-
Total reported value, excl. options
-
$9,469,175,078
-
Value change
-
-$1,193,875,685
-
Put/Call ratio
-
192%
-
Number of buys
-
218
-
Number of sells
-
378
-
Price
-
$17.60
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q3 2017
753 filings reported holding TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share as of 30 Sep 2017.
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) had 518 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 538,274,425 shares of stock of the company.
Largest 10 holders included FRANKLIN RESOURCES INC, Capital Research Global Investors, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., FMR LLC, HIGHFIELDS CAPITAL MANAGEMENT LP, Northern Cross, LLC, ABRAMS CAPITAL MANAGEMENT, L.P., Bank of New York Mellon Corp, and ALLIANCEBERNSTEIN L.P..
This table shows the top 518 institutional shareholders of the security as of 30 Sep 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.